Kathryn A. Tunstall, Chairman of the Board of Directors since January 2000, has served as one of the Compnay's directors since July 1993 and served as the Company's President and Chief Executive Officer from July 1993 to December 1999. Prior to joining the Company, Ms. Tunstall spent seven years as an executive officer of the Edwards Less Invasive Surgery Division of Baxter International, a division engaged in the research and development, manufacturing and marketing of cardiovascular catheters, serving as President from June 1990 to June 1993 and serving as Vice President and Director of Worldwide Sales and Marketing from November 1986 to June 1990. From 1974 to 1986, Ms. Tunstall held various positions in finance, operations and marketing in two divisions of American Hospital Supply Corporation, including that of Vice President of Marketing of McGaw Laboratories, a pharmaceutical and medical device company. Ms. Tunstall also currently serves as a director and as Compensation Committee Chair of Caliper Lifesciences, a public biotechnology company and is Chairman of the Board of NeoMatrix, a private company involved in breast cancer screening. Ms. Tunstall holds a B.A. in Economics from the University of California and has also completed graduate level studies in Business and Healthcare Administration.

Robert V. Toni was appointed to the Company's Board of Directors in October 2003. Mr. Toni retired in October 2002 from Closure Medical Corporation, where he held the position of President and Chief Executive Officer and served on the Executive Committee for eight years. Previous to Closure Medical, Mr. Toni was General Manager of Iolab Corporation for five years and held a number of senior positions with Coopervision Cilco for seven years with his last position being President. Mr. Toni's earlier career was primarily in financial management for several large companies, including AMF and General Motors where he held the positions of Controller and Accounting Manager, respectively. He holds a B.B.A. from Iona College.

Thomas F. Bonadio was appointed to the Company's Board of Directors in September 2003. Mr. Bonadio is the founder and managing partner of The Bonadio Group, an independent provider of accounting, business advisory and financial services in the upstate New York area and a top 100 certified public accounting firm in the United States. He founded this business in 1978, following seven years with Arthur Andersen & Co. Mr. Bonadio is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. He holds a B.B.A. from St. John Fisher College, and is the past chairman of St. John Fisher College's Board of Trustees.

Paul A. LaViolette was appointed to the Company's Board of Directors in December 2008. Mr. LaViolette currently serves on the Board of Directors of DJO, Cameron Health, Trans1, Inc. and Direct Flow Medical, Inc. and is a Venture Partner with SV Life Sciences Advisers, LLC. Mr. LaViolette most recently served as Chief Operating Officer of Boston Scientific Corporation until his retirement in June 2008. He joined Boston Scientific in January 1994 and had been COO since 2004. During his 15-year career at Boston Scientific, Mr. LaViolette ran the International, Endosurgery, Interventional Cardiology and Cardiovascular businesses. Prior to joining Boston Scientific, he spent 10 years with C.R. Bard, Inc. Mr. LaViolette holds a B.A. from Fairfield University and an M.B.A from Boston College.